SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring-mounted Halcyon Linac

Damodar Pokhrel, Aaron Webster, Joseph Stephen, William St Clair

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Purpose/objectives: This work seeks to evaluate the plan quality, treatment delivery efficiency, and accuracy of single-isocenter volumetric modulated arc therapy (VMAT) of abdominal/pelvic oligometastatic lymph nodes (LNs) stereotactic body radiation therapy (SBRT) on Halcyon Linac. Materials and Methods: After completing the in-house multitarget end-to-end phantom testing and independent dose verification using MD Anderson’s single-isocenter/multi-target (lung and spine target inserts) thorax phantom, eight patients with two to three abdominal/pelvic oligometastatic LNs underwent highly conformal single-isocenter VMAT-SBRT treatment using the Halcyon Linac 6MV flattening filter free (FFF) beam. Targets were identified using an Axumin PET/CT scan co-registered with planning CT images and a single-isocenter was placed between/among the targets. Doses between 25 and 36.25 Gy in 5 fractions were delivered. Patients were treated every other day. Plans were calculated in Eclipse with advanced AcurosXB algorithm for heterogeneity corrections. For comparison, Halcyon VMAT-SBRT plans were retrospectively generated for SBRT-dedicated TrueBeam with a 6MV-FFF beam using identical planning geometry and objectives. Target coverage, conformity index (CI), dose to 2 cm away from each target (D2cm) and dose to adjacent organs-at-risk (OAR) were evaluated. Additionally, various treatment delivery parameters including beam-on time were recorded. Results: Phantom measurements showed acceptable spatial accuracy of conebeam CT-guided Halcyon SBRT treatments including compliance with MD Anderson’s single-isocenter/multi-targets phantom credentialing results. For patients, the mean isocenter to tumor center distance was 3.4 ± 1.2 cm (range, 1.5–4.8 cm). The mean combined PTV was 18.9 ± 10.9 cc (range, 5.6–39.5 cc). There was no clinically significant difference in dose to LNs, CI, D2cm and maximal doses to OAR between single-isocenter Halcyon and Truebeam VMAT-SBRT plans, although, Halcyon plans provided preferably lower maximal dose to adjacent OAR. Additionally, total monitor units, beam-on time and overall treatment time was lower with Halcyon plans. Halcyon’s portal dosimetry demonstrated a high pass rate of 98.1 ± 1.6% for clinical gamma passing criteria of 2%/2 mm. Conclusion: SBRT treatment of abdominal/pelvic oligometastatic LNs with single-isocenter VMAT on Halcyon was dosimetrically equivalent to TrueBeam. Faster treatment delivery to oligometastatic LNs via single-isocenter Halcyon VMAT can improve clinic workflow and patient compliance, potentially reducing intrafraction motion errors for well-suited patients. Clinical follow-up of these patients is ongoing.

Original languageEnglish
Pages (from-to)162-171
Number of pages10
JournalJournal of Applied Clinical Medical Physics
Volume22
Issue number6
DOIs
StatePublished - Jun 2021

Bibliographical note

Funding Information:
This work is partially supported by the Varian Medical Systems.

Publisher Copyright:
© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of American Association of Physicists in Medicine

Keywords

  • AcurosXB
  • Coplanar Geometry
  • FFF-beam
  • Halcyon Linac
  • oligometastatic lymph nodes SBRT
  • single-isocenter VMAT

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring-mounted Halcyon Linac'. Together they form a unique fingerprint.

Cite this